pH-Responsive Aβ Probe for Microglial Phagocytosis Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying microglial phagocytosis of amyloid beta (Aβ) in Alzheimer's disease are hindered by sustained fluorescence and inability to distinguish between internalized and surface-bound Aβ, making it difficult to differentiate functional and dysfunctional microglial cells.
Innovation Solution
Development of a pH-dependent fluorescent Aβ-dye conjugate that is non-fluorescent at neutral physiological pH but emits strong fluorescence in acidic intracellular phagosomes, allowing specific visualization of Aβ uptake by microglial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fluorescent-labeled Aβ peptides are used to study microglial phagocytosis, then specificity to microglia in Alzheimer's brain microenvironment is improved, but ability to distinguish between Aβ inside the cell versus on the cell surface deteriorates
Solution Approach 1:
The patent applies parameter changes by utilizing pH as a distinguishing parameter. The fluorescent dye is selected to be pH-sensitive, remaining non-fluorescent at neutral extracellular pH (7.4) and becoming fluorescent only in the acidic environment of phagosomes (pH 4.5-5.5). This allows specific detection of internalized Aβ while excluding surface-bound Aβ, resolving the contradiction between maintaining specificity and achieving measurement precision.
Solution Approach 2:
The patent uses pH as an intermediary parameter to indirectly detect Aβ internalization. Instead of directly observing Aβ location, the method employs pH-sensitive fluorescence as a mediator that reports on the intracellular acidic environment of phagosomes, thereby enabling distinction between internalized and surface-bound Aβ without directly interfering with the phagocytosis process.
2Ease of manufacture
If conventional fluorescent reagents are used to track Aβ uptake, then visualization of phagocytic process is enabled, but real-time differentiation of phagocytic and non-phagocytic microglial cells deteriorates
Solution Approach 1:
The patent employs parameter changes by utilizing pH-dependent fluorescence activation. The dye remains non-fluorescent at neutral pH in the extracellular environment and only becomes fluorescent when Aβ is internalized into acidic phagosomes. This enables real-time differentiation of phagocytic cells (which show fluorescence) from non-phagocytic cells (which remain non-fluorescent), resolving the contradiction between ease of visualization and measurement precision.
3Duration of action of moving object
If sustained fluorescence reagents are used, then continuous monitoring is possible, but distinction between functional and dysfunctional microglial cells deteriorates
Solution Approach 1:
The patent applies parameter changes by using pH-responsive fluorescence that is activated only in acidic compartments. This allows continuous monitoring of phagocytosis over time while maintaining the ability to distinguish functional microglial cells (which form acidic phagosomes and show fluorescence) from dysfunctional cells (which fail to acidify phagosomes and remain non-fluorescent), thereby resolving the contradiction between duration of action and measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables real-time differentiation of phagocytic and non-phagocytic microglial cells, facilitating accurate live-cell imaging and flow cytometry analysis of Aβ-specific phagocytosis.
Implementation Method 1
F is a pH-responsive fluorophore or dye... The fluorescent property of this dye is pH dependent i.e. non-fluorescent at neutral physiological pH of a cell or a biological system (̃7.4) but gives a strong green fluorescence signal in the acidic pH, ranging from about pH 2 to about pH 5, microenvironment of the phagosome
Data Source
AI summary
The present invention generally relates to a composition matter useful for diagnosis and treatment of Alzheimer's disease comprising A-L-F or a pharmaceutically acceptable salt thereof, wherein A is beta-amyloid peptide or a fragment thereof, L is an optional linker and F is a pH-responsive fluorophore, dye, or a therapeutic agent. Composition matters, methods of use as well as a kit for diagnosis and/or treatment of Alzheimer's disease are within the scope of this disclosure.